Kun Mu

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Drug Administration

Endoplasmic Reticulum

Breast Cancer Risk

Top Venues

The Journal of experimental medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Xu Li, Shu Zhuo, Ting Zhuang, Yong Suk Cho, Guojin Wu, Yuchen Liu, Kun Mu, Kai Zhang, Peng Su, Yingzi Yang, Cheng Cheng Zhang, Jian Zhu, Jin Jiang
YAP inhibits ERα and ER + breast cancer growth by disrupting a TEAD-ERα signaling axis. Nature communications 13 (1) (2022)
Cuiyu Zhang, Yu-Ping Zhou, Junjie Zheng, Nannan Ning, Haining Liu, Wenyang Jiang, Xin Yu, Kun Mu, Yan Li, Wei Guo, Huili Hu, Jing Xin Li, Dawei Chen
Inhibition of GABAA receptors in intestinal stem cells prevents chemoradiotherapy-induced intestinal toxicity. The Journal of experimental medicine 219 (12) (2022)